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Summary
Vitamin D is fat-soluble. It is suggested to be taken
with meals containing fat to enhance its intestinal
absorption. However, there are only a few controlled
studies which investigate prandial inferences on its
absorption.
Within a group of 13 general practitioners, during a
period of three months, we ran two identical study
protocols during winter and early springtime. Blood
was taken from the subjects, 60’000 units of vitamin D
(cholecalciferol) in 3 ml of oil was ingested, and blood
was sampled once again a week later.  In a
randomized cross-over design, one time the vitamin
was ingested postprandially, and another time in a
fasting state.
The basal levels of 25-hydroxyvitamin D were 45 (28)
(median, interquartile range) before fasting, and 40 (15)
nmol/l before postprandial dosing. One week
thereafter, serum 25-hydroxyvitamin D was increased
by 13 (21), when the supplement was ingested in a
fasting state, while taken after a meal containing fat,
the rise was 25 (17) nmol/l (n.s., p=0.13). The other
parameters which were tested remained unchanged
throughout the study: calcium, phosphate, albumin,
and 1,25?dihydroxyvitamin D (calcitriol).
Our preliminary data do not support major influences
on vitamin D absorption by the influence of fasting vs.
concomitant fatty meal intake. Vitamin D oral loading
doses can be applied irrespective of prandial state,
while its maintenance dosing by the patients should
still take place after a meal containing fat. Absorption
of vitamin D seems to be unpredictable – fractionate
dosage and determination of 25-hydroxyvitamin D
during treatment may be helpful. Unexplained low
serum levels after repeated supplementation could be
due to intestinal disease, mainly celiac.
Introduction
There are no natural food sources which guarantee an
optimal supply of vitamin D to the populations of most
industrialized countries. We depend on sunlight for
vitamin D production via UV-B radiation. But in regions
of latitudes higher than 45o, sunlight does not enable
people to produce sufficient amounts of vitamin D from
autumn through spring. Thus, because the half-life of
vitamin D is about one month, nearly all inhabitants of
these regions will get vitamin D levels in the
insufficiency (<50 nmol/l) or deficiency (<25 nmol/l)
ranges from winter until  spring unless they take
supplements [1]. Concerns about skin cancer have
caused the widespread use of sun blocks which limit
vitamin D synthesis even in the summertime.
Classically, vitamin D deficiency evolves with
osteomalacia and osteoporosis or osteopenia,
respectively. There are several diseases which are
associated with vitamin D deficiency: hypertension,
atherosclerosis, diabetes, asthma, colon cancer,
multiple sclerosis, migraines, Parkinson’s disease,
seasonal depression, neurodermitis, psoriasis,
collagenosis and susceptibility to infection (especially
tuberculosis) [2]. Groups of patients prone to getting
hypovitaminosis D include those with sun allergies or
sk i n  cance r ,  t r ansp lan ta t i on  pa t i en t s
(immunosuppressed) who avoid sunlight, dark-skinned
or adipose persons, smokers, patients with
inflammatory or celiac bowel disease, elderly persons,
and especially people who have been institutionalized
[3].
Vitamin D is a member of the group of fat-soluble
vitamins. This may be a reason for the widespread
advice to take it together with a meal containing fat.
However we found little published evidence supporting
this notion. Stoll et al have recently investigated the
nutritional dependency of vitamin D, but the test
conditions were not standardized, and the results were
only published as a congress poster [4]. Tangpricha et
al. found no evidence of food dependency on vitamin
D2 (ergocalciferol) absorption [5]. In contrast, Viegas
Ramondo et al described better absorption of Vitamin
D3 (cholecalciferol) when taken with a meal containing
26 g of fat as compared to a meal with only two g of fat
[6].
Vitamin D can by administered orally or by
intramuscular injection. However, the latter can lead to
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painful granuloma at the injection site [7], hemorrhage
and infections, and absorption of the vitamin can be
delayed. This may explain why injections can result in
prolonged therapeutic blood levels of vitamin D as
compared to when administered orally [8, 9]. For
practical reasons it would be useful if oral vitamin D
supplements could be administered independently of
meals, e.g. in the practice of the physician who is in
care of the patient.
Vitamin D is stored within fat tissue. Its half-life of
about one to two months and its lack of toxicity allows
it to be given on a daily, weekly or monthly basis.
Intestinal absorption of vitamin D seems to follow two
phases: firstly, it is rapidly absorbed into the mucosa
cells, and later on, it is enclosed into chylomicron
particles which are delivered into the thoracic duct.
The latter depends on the presence of food
triglycerides and therefore also pancreatic and bile
enzyme activity within the intestinal lumen [10].
Monounsaturated and saturated fatty acids increase
vitamin D absorption as compared to polyunsaturated
ones [11 ] .  In  cont ras t  to  i t s  p recursor ,
25?hydroxyvitamin D (calcidiol) is transported via the
portal vein to the liver, independently from chylomicron
particles [10,12,13]. This may explain why it is
absorbed more constantly and generally better than its
non-hydroxylated precursor molecule [14]. The
pharmaceutical industry has produced Fosavance®, a
compound containing vitamin D and alendronate, an
oral bisphosphonate that must strictly be taken while
fasting. Nonetheless, with Fosavance a reproducible
and dose-dependent uptake of vitamin D has been
demonstrated [15].
Aims of the study: To test in a pilot study whether oral
cholecalciferol is absorbed differently when taken in a
fasting as compared to a postprandial state.
Subjects and Methods
13 practicing healthy male family physicians (GP),
members of the “Quality Circle Oberthurgau” took part
in this trial.
Venous blood was drawn and thereafter 3 ml of
vitamin D Wild Company (medium cat triglyceride oily
drops), containing 60’000 E cholecalciferol, were taken
in a fasting or postprandial state. One week later,
blood was sampled again. After an interval of three
months, the same procedure took place, but the
circumstances of supplementation were changed, from
fasting to postprandial, and vice versa. In a
randomized order, seven participants started with the
postprandial intake.
The following data were registered: age, smoking
habits, height, weight, blood pressure, and heart rate.
Serum was tested for: calcium, phosphate, albumin,
25-hydroxy- and 1,25?dihydroxyvitamins D.
Null hypothesis
1. The increase in serum 25-hydroxyvitamin D one
week after a dose of 60’000 E cholecalciferol in 3 ml of
oily solution is not enhanced by a concomitant
principal meal containing a variable quantity of fat.
2. The serum levels of 25-hydroxyvitamin D are
comparable three months after postprandial vs. fasting
dosage of cholecalciferol.
Inclusion criteria: practicing GP, healthy, informed
consent.
Exclusion criteria: chronic inflammatory or celiac
bowel disease, intake of supplements containing
vitamin D, tropical holidays, and solarium visits.
Laboratory methods: serum calcium, phosphate and
albumin were assessed with standard laboratory tests.
Vitamin D values were determined with AMP RIA CT
(1,25 D3, radioimmunoassay) or ADVIA CENTAUR
vitamin D total (25 OH D3, immunoassay). The latter
has an inter-assay variation coefficient (CV) of 5 to 11
%  d e p e n d i n g  o n  t h e  c o n c e n t r a t i o n  o f
25-hydroxyvitamin D (higher CV with lower
concentrations). This was the reason we calculated
mean values from duplicate determinations on
separate day assays. In the case of discrepancies of
more than 15%, a third analysis was done, and the
mean value was calculated between the third value
and the one closer to it.
Statistics
Values are given as median (interquartile range [IQR]).
Differences of the eighth day vitamin D level increases
after postprandial vs. fasting vitamin dosage were
assessed by paired T-testing, while differences of the
three months of vitamin D level increases were
analyzed by a simple T-Test. Because this was a pilot
study with a closed group of physicians, we did not
apply a pre-study power calculation.
Results
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13 healthy male GPs participated in the study. The
first set of study determinations took place from 1st
December 2011 to 1st February 2012, and the dates of
the second set were from 24th February 2012 to 17th
April 2012. On the second term, one participant
erroneously took 200’000 instead of 60’000 units of
vitamin D, so the values of his last blood sample were
excluded from the study. His individual values (blood
levels before and after postprandial vitamin dosing)
were: calcium 2.39 / 2.33 mmol/l, 25-hydroxyvitamin D
42 / 131 nmol/l and 1,25-dihydroxyvitamin D 39 / 67
ng/l. In one blood sample, only a single determination
of 25?hydroxyvitamin D was possible because of a
lack of the quantity of serum; all other determinations
took place per protocol.
The baseline data of the participants are summarized
in Table 1. One participant is a smoker.  When
correcting total calcium for albumin values, levels were
2.27 (0.18) or 2.30 (0.14) mmol/l before fasting and
postprandial dosing, respectively /l. Values of calcium
(either corrected by albumin values or not), phosphate,
albumin and 1,25?dihydroxyvitamin D were
unchanged throughout the study. The individual
courses of 25-hydroxyvitamin D level increases are
depicted in Figure 1. Fasting intake of vitamin D
resulted in a median increase of 13 (21) nmol/l, while
increase after a meal containing fat was 25 (17) nmol/l
(n.s., p=0.13). Three months after intake of the first
vitamin dose, the increase of 25-hydroxyvitamin D was
9 (19) nmol/l after fasting vitamin intake (n=6) as
compared to 7 (21) (n=7) after postprandial intake
(n.s.). The time interval between the first vitamin dose
and the third blood sampling was 84 (3) days. The
time interval after the vitamin ingestion and up until
blood sampling was 164 (7) hours for postprandial and
168 (22) for fasting intake (n.s.). 10’000 units of
vitamin D given orally were calculated to rising blood
levels of 25-hydroxyvitamin D by 2.9 (2.6) nmol/l.
Discussion
Our study has revealed two major insights on vitamin
D oral absorption. Firstly, there is no clinically relevant
group difference between cholecalciferol postprandial
vs. fasting absorption. A loading dose can be applied
orally as needed at the doctor’s surgery independent
of whether the patient has eaten or not. Secondly,
there is a large unpredictability of the rise of
25-hydroxyvitamin D levels after single oral
supplements.  
In their dosage study, Viegas Raimundo et al. did not
find any rise in 25-hydroxvitamin D levels after
administering 50’000 E cholecalciferol together with a
meal containing 2.6 g fat on day seven or fourteen [6].
In our study, supplements consisted of 60’000 E
cholecalciferol in a medium cat triglyceride oily
solution, making the quantity of fat similar for both
studies. However, in the fasting state, the supplements
were administered without a meal. Perhaps the higher
fiber content of the low fat meal [6] effectively blocked
the absorption of vitamin D as compared to our
subjects, who remained in a fasting state for at least
another four hours.
A study on prandial inference on vitamin D absorption
was conducted by Wagner et al [16]. In elderly
patients, 28’000 E cholecalciferol in 1 ml of alcoholic
solution was given together with a meal containing fat
or in a fasting state for two months on a weekly basis.
There was only a minimal difference to support
postprandial as compared to fasting ingestion of the
supplements.
Denker et al. described a maximal 24-fold individual
variation between the areas under the curve of vitamin
D serum levels after fasting intake of single
cholecalciferol supplements [15], but there was no
control  group taking vi tamin supplements
postprandially, because the pills also contained the
bisphosphonate alendron, which has to be taken
strictly in a fasting state.
For these reasons, it seems wise to fractionate loading
doses into several smaller proportions to achieve more
reliably target levels of vitamin D. Patients taking oral
vitamin D supplements for diseases like osteoporosis
or myopathy with a magnesium deficiency must be
tested for reaching 25-hydroxyvitamin D target levels,
and thereafter the dosages of the supplements should
be appropriately adapted. Perhaps in the future,
25-hydroxyvitamin D supplements (calcidiol) will
provide more predictable results [14, 17].
In our study, we did not find any difference of
1,25-dihydroxyvitamin D levels before vs. eight day
after ingestion of the supplement. Serum levels of this
active metabolite of vitamin D however are highly
regulated, so in healthy physicians and after a
moderate dosage of cholecalciferol, this finding is not
surprising.
Limitations
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We aimed to conduct our study not under
sophisticated experimental conditions, but rather
everyday practical ones. So we sent our samples to a
commercial laboratory which works together with most
of us. Furthermore, the dosage of vitamin D was quite
low (60’000 E are close to the twofold recommended
monthly dose). These circumstances and the large
variability of the laboratory determinations of
25-hydroxyvitamin D [18, 19] impaired to some degree
our being able to make clear conclusions from our
analysis. Within the lower range of serum levels as
measured in this study, the manufacturer’s brochure
mentions a CV of 11.1%. This value compares to the
36 % (fasting) to 59 % (postprandial) increases in
25-hydroxyvitamin D serum levels one week after
dosing. As a security measure, we did double or
(when necessary) tr iple determinations of
25-hydroxyvitamin D.
Post-hoc power analysis revealed that with the given
variability of vitamin D absorption and only 12
participants, we had only a 40% chance of detecting
prandial differences of 33% and more, and the study
was therefore underpowered.
We used Wild oily vitamin D drops in our study for two
main reasons: Firstly, we wanted to use preparations
which were accessible to general practitioners.
Secondly, we had no ethical committee permission for
this study (this would have implied getting a
Swissmedic drug authority notification), which led us to
use only preparations admitted for the given indication
(i.e. oral supplementation in suspected vitamin D
deficiency), the given dosing and the given route of
administration. ViDe3® alcoholic drops are also
admitted for oral supplementation, but 60’000 E of
them would contain ca. 10 ml of alcohol which per se
could affect gastrointestinal absorption of vitamin D
and would be inacceptable for the participants.
In some institutions in Switzerland, it is a common
practice to start vitamin D therapies by orally
administering a loading dose of injectable vitamin D
ampoules (Streul i )  contain ing 300’000 E
cholecalciferol dissolved in 1 ml of medium chain
triglycerides. 0.2 ml would contain the same amount of
vitamin D as used in our protocol, but measuring and
applying it by the participants would have entailed
severe accuracy problems. Furthermore, the
ampoules are only admitted for parenteral use.
Our experimental solution contained 3 ml of oil. Indeed,
intake of a similar quantity of lipids (0.3 ml/min of
duodenal Intralipid® 10%, corresponding to 0.25
kcal/min or 0.03 g/min of soybean oil) caused a slight
but not persistent rise in cholecystokinin serum
concentrations and perhaps gall bladder contraction
[20]. This could have blurred the effect of prandiality in
our study data. But if this was the case, the question
whether vitamin D could also be administered orally to
fasting subjects would have to be answered in the
affirmative, provided that a similar quantity of oil is
given concomitantly with the vitamin.
Or subjects were instructed to administer the
postprandial vitamin dosing after a principal meal
containing fat, however the composition of the meal
was not specified to them.
We did not measure blood levels of vitamin D
(cholecalciferol), so we were not able to distinguish its
absorption differences from those in 25-hydroxylation
metabolism. Perhaps the interval of eight days was too
short to produce stable 25?hydroxyvitamin D serum
levels, since 14 days after dosage 25?hydroxyvitamin
D levels were still rising, as demonstrated by Viegas
Raimundo et al [6]. However, since our subjects were
their own controls, and three months after ingestion of
the first vitamin D supplement there was no significant
difference in the serum levels achieved, this seems
not to be a source of major concern for our data.
Conclusions
Our preliminary data do not support major influences
on vitamin D absorption by the influence of fasting vs.
concomitant fatty meal intake. Vitamin D oral loading
doses can be applied irrespective of prandial state,
while its maintenance dosing by the patients should
still take place after a meal containing fat. However,
individual absorption of vitamin D seems to be
unpredictable – fractionate dosage and determination
of 25-hydroxyvitamin D serum levels during treatment
may be helpful. Hence, as vitamin D is cheap and
non-toxic; small differences in its intestinal absorption
may not be clinically relevant. Unexplained low
25-hydroxyvitamin D levels after repeated
supplementation could be due to intestinal disease,
mainly celiac.
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Illustrations
Illustration 1
Figure 1. Individual increases of serum 25-hydroxyvitamin D after 8 days as compared to pre-dosage levels (n=12).
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Age, years 55 (7)
Body mass index, kg/m2 23.1 (3.3)
Blood pressure, mmHg 130 / 84 (21 / 12)
Heart rate, min-1 72 (20)
Study phase before fasting dosing before postprandial dosing
Serum calcium, mmol/l 2.37 (0.12) 2.40 (0.12)
Serum phosphate, mmol/l 1.15 (0.20) 1.15 (0.37)
Serum albumin, g/l 43.5 (3.0) 44.5 (4.3)
25-hydroxyvitamin D, nmol/l 45 (28) 40 (15)
1,25-dihydroxyvitamin D, ng/l 38 (26) 39 (16)
Median values (IQR), n=12.
Illustration 2
Table 1. Baseline values (n=13)
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